Status:
COMPLETED
A Study of NeoRecormon in Patients With Chronic Kidney Disease.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This 2 arm study will compare the level of anemia, and the decline in renal function, between patients receiving NeoRecormon, and those not receiving it. Patients with chronic kidney disease, stage 2-...
Eligibility Criteria
Inclusion
- adult patients,18-75 years of age;
- end-stage renal disease, not on dialysis;
- Hb \<110g/L.
Exclusion
- unstable hypertension;
- acute infections;
- use of i.v. NeoRecormon, or use of any other ESA beside NeoRecormon;
- myocardial infarction, unstable angina or venous thrombosis within 6 months before start of treatment.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00437723
End Date
April 1 2008
Last Update
May 14 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Belgrade, Serbia, 11000
2
Novi Sad, Serbia, 21000